← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2014Last known activity
Nov 13, 2024
Timeline
1990s
- Jan 1, 1999
MonitorCRO— Founded
Drugs by trial phase (26 distinct, 16 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Candidiasis, Vulvovaginal
- Fatty Liver
- Fever
- Hemorrhagic Fever, Crimean
- Hemorrhagic Fevers, Viral
- Infections
- Liver Diseases
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Non-alcoholic Fatty Liver Disease
- Pharyngitis
- Sclerosis
- Trichomonas Vaginitis
- Vaginal Diseases
- Vaginitis
- Vaginosis, Bacterial
- Vulvovaginitis
Recent trials (17)
- NCT06781632CollaboratorPhase 1Nov 13, 2024
- NCT05706870CollaboratorPhase 2Dec 7, 2022
- NCT05361369CollaboratorPhase 1May 9, 2022
- NCT05428202CollaboratorPhase 1Mar 28, 2022
- NCT05428202Study directorPhase 1Mar 28, 2022
- NCT04962893CollaboratorPhase 2Jun 26, 2021
- NCT04828564CollaboratorPhase 2/Phase 3Apr 30, 2021
- NCT04866069CollaboratorPhase 1Apr 25, 2021
- NCT04818281CollaboratorPhase 1Mar 27, 2021
- NCT04573153CollaboratorPhase 2/Phase 3Sep 21, 2020
- NCT06056947CollaboratorPhase 3Jul 20, 2020
- NCT04330326CollaboratorPhase 2Jul 20, 2019
- NCT03839875CollaboratorPhase 4Apr 30, 2019
- NCT03283397CollaboratorPhase 3Nov 4, 2018
- NCT03282045CollaboratorPhase 3Oct 31, 2016
Details
- Founded
- TR Jan 1, 1999
- Last known activity
- Nov 13, 2024